-
07-08-2004, 02:34 PM #1New Member
- Join Date
- Jun 2004
- Posts
- 11
what would be the best steroid to take to get cut
what would be the best steroid to get cut....Im a really big broad type of person but i wanna get a lil definition
-
07-08-2004, 02:35 PM #2
Have you done any cycles before? How old are you?
-
07-08-2004, 02:36 PM #3
take some test and hop on the treadmill to lose fat and retain muscle.
there isn't a "cutting" steroid .
closest thing would be HGH, and it requires 3 months of use for noticable results.
-
07-08-2004, 02:37 PM #4New Member
- Join Date
- Jun 2004
- Posts
- 11
well this is 4 my friend im describing him....but know he hasnt he's really big guy...im just tryin to help him out
-
07-08-2004, 02:38 PM #5Associate Member
- Join Date
- Jun 2004
- Location
- Earth
- Posts
- 429
how about a sound diet and spot on training? thats a must...
other than that, i would recommend clen along with an ECA stack for off weeks. do some research on Clen and ECA before you start though...
-
07-08-2004, 02:38 PM #6New Member
- Join Date
- Jun 2004
- Posts
- 11
ight thanks man
-
07-08-2004, 03:08 PM #7Originally Posted by daos
-
07-08-2004, 04:43 PM #8
prop and tren ....combined are great for cuts...
-
07-08-2004, 04:48 PM #9
How old is your "friend"??
-
07-08-2004, 04:49 PM #10
Do some research. If you had, then you would know that you can get 'cut' with any steroid . Steroids are used for dieting to maintain the muscle, granted the androgen receptor and other mechanisms can cause fatloss but its not like they will burn a terrific amount of fat for you.
Research!
BTW, how old is this 'freind?'
-
07-08-2004, 05:24 PM #11
Oxandrolone cuts me to shreds. Although fina probably has the most dramatic effects of all. Here is one study on ox, however. I could find some more if you'd like. And sorry for it being all jumbled - cutting and pasting didn't work out too good...
Abstract: AS decreases fat
Title
Oral anabolic steroid treatment, but not parenteral androgen treatment,
decreases abdominal fat in obese, older men.
Author
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C;
Tulley R
Address
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808-4124, USA.
Source
Int J Obes Relat Metab Disord, 19: 9, 1995 Sep, 614-24
Abstract
OBJECTIVE: To compare the effects of testosterone enanthate (TE),
anabolic steroid (AS) or placebo (PL) on regional fat distribution and
health risk factors in obese middle-aged men undergoing weight loss by
dietary means.
DESIGN: Randomized, double-blind, placebo-controlled clinical trial,
carried out for 9 months with primary assessments at 3 month intervals.
Due to adverse blood lipid changes, the AS group was switched from oral
oxandrolone (ASOX) to parenteral nandrolone decaoate (ASND) after the
3 month assessment point.
SUBJECTS: Thirty healthy, obese men, aged 40-60 years, with serum
testosterone (T) levels in the low-normal range (2-5 ng/mL).
MAIN OUTCOME MEASURES: Abdominal fat distribution
and thigh muscle volume by CT scan, body composition by dual energy
X-ray absorptiometry (DEXA), insulin sensitivity by the Minimal Model
method, blood lipids, blood chemistry, blood pressure, thyroid
hormones and urological parameters.
RESULTS: After 3 months, there was a significantly greater decrease in subcutaneous (SQ) abdominal fat in the ASOX group compared to the TE and PL groups although body
weight changes did not differ by treatment group. There was also a
tendency for the ASOX group to exhibit greater losses in visceral fat,
and the absolute level of visceral fat in this group was significantly
lower at 3 months than in the TE and PL groups. There were significant
main effects of treatment at 3 months on serum T and free T (increased
in the TE group and decreased in the ASOX group) and on thyroid hormone
parameters (T4 and T3 resin uptake significantly decreased in the ASOX
group compared with the other two groups). There was a significant
decrease in HDL-C, and increase in LDL-C in the ASOX group,
which led to their being switched to the parenteral nandrolone decanoate
(ASND) after 3 months. ASND had opposite effects on visceral fat from
ASOX, producing a significant increase from 3 to 9 months while
continuing to decrease SQ abdominal fat. ASND treatment also decreased
thigh muscle area, while ASOX treatment increased thigh muscle. ASND
reversed the effects of ASOX on lipoproteins and thyroid
hormones. The previously reported effect of T to decrease visceral fat
was not observed, in fact, visceral fat in the TE group increased
slightly from 3 to 9 months, although SQ fat continued to decrease.
Neither TE nor AS treatment resulted in any change in urologic
parameters.
CONCLUSIONS: Oral oxandrolone decreased SQ abdominal fat more than TE or weight loss alone and also tended to produce favorable
changes in visceral fat. TE and ASND injections given every 2 weeks
had similar effects to weight loss alone on regional body fat.
Most of the beneficial effects observed on metabolic and cardiovascular
risk factors were due to weight loss per se. These results suggest that
SQ and visceral abdominal fat can be independently modulated by
androgens and that at least some anabolic steroids are capable of
influencing abdominal fat.
-
07-08-2004, 11:26 PM #12Originally Posted by footballplayer15
Thread Information
Users Browsing this Thread
There are currently 1 users browsing this thread. (0 members and 1 guests)
How to not stress about a heart...
Yesterday, 10:41 PM in ANABOLIC STEROIDS - QUESTIONS & ANSWERS